Workflow
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs

Group 1 - WeightWatchers CEO Sima Sistani has stepped down after 2½ years, with Tara Comonte appointed as interim CEO [1] - During Sistani's tenure, WeightWatchers acquired telehealth platform Sequence, now known as WeightWatchers Clinic, to expand into obesity drug prescriptions [2] - The company's shares have dropped approximately 90% this year, largely due to the rising popularity of GLP-1 drugs like Ozempic and Wegovy, which have affected its traditional weight loss program [2] Group 2 - The company reaffirmed its full-year 2024 forecast for revenue and adjusted operating income [4] - Comonte joined the WeightWatchers board in June 2023 and has prior experience as CEO of TMRW Life Sciences and as president and CFO of Shake Shack [3]